Diabetes Center Berne
Overview
A private, independent Swiss foundation established in 2017 with the aim of making life with diabetes easier. Through its 'DCB Innovation' arm, it runs the 'DCB Open Innovation Challenge' to identify, fund, and support innovative ideas and projects in the field of diabetes technology worldwide.
Portfolio Companies
6
Website
dcberne.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| GlucoSet | Nov 2021 | Grant | Co-investor |
| MYNERVA AG | Nov 2023 | Grant | Co-investor |
| SmartStart Health | Apr 2022 | Grant | Co-investor |
| Enhance-d | - | Grant | Co-investor |
| Eclypia | Nov 2023 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Diabetes Center Berne based?
Diabetes Center Berne is headquartered in Bern, Bern, Switzerland.
When was Diabetes Center Berne founded?
Founding year information for Diabetes Center Berne is not publicly available.
How many portfolio companies does Diabetes Center Berne have?
Diabetes Center Berne has 6 portfolio companies in Caplight's dataset.
What are some companies in Diabetes Center Berne's portfolio?
Portfolio companies visible on Caplight include GlucoSet, MYNERVA AG, SmartStart Health, Enhance-d, Eclypia.
What was Diabetes Center Berne's most recent investment shown here?
Diabetes Center Berne's most recent investment in this portfolio sample was in MYNERVA AG in 2023.
What sectors does Diabetes Center Berne focus on?
Diabetes Center Berne focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Diabetes Center Berne focus on?
Stage focus information for Diabetes Center Berne is not publicly available.